By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GI Dynamics 

Boston  Massachusetts    U.S.A.
Phone: 617-454-6025 Fax:


Medical Device

Company News
German Diabetes Society Releases Statement Regarding GI Dynamics (GID.AX)’ Termination of U.S. ENDO Trial 9/28/2015 1:28:59 PM
GI Dynamics (GID.AX) Axes Workforce by 46% 8/21/2015 7:05:18 AM
GI Dynamics (GID.AX): Appendix 4C Quarterly Report Quarter Ended 30 June 2015 7/30/2015 1:34:42 PM
GI Dynamics (GID.AX) Discontinues U.S. Trial of EndoBarrier Therapy 7/30/2015 7:56:21 AM
GI Dynamics (GID.AX) Release: New Data Presented At American Diabetes Association Demonstrate Early Effect Of Endobarrier Therapy On Glucose Control And Bile Acid Regulators 6/8/2015 11:28:39 AM
GI Dynamics (GID.AX): Appendix 4C Quarterly Report Quarter Ended 31 March 2015 4/30/2015 12:41:43 PM
GI Dynamics (GID.AX) Stock Freefalls After FDA Halts Trial 3/6/2015 6:40:56 AM
GI Dynamics (GID.AX) To Axe 10% Of Workforce 12/10/2014 6:21:05 AM
GI Dynamics (GID.AX) Resumes Shipments Of EndoBarrier® Product 12/1/2014 12:37:15 PM
GI Dynamics (GID.AX) Shares Belted Over Suspension Of Obesity Device In Europe 10/9/2014 7:10:33 AM